Loading...

Jong Rho

Title(s)Associate Physician Diplomate, Neurosciences
SchoolHealth Sciences
vCardDownload vCard

    Collapse Research 
    Collapse Research Activities and Funding
    Mechanisms of Seizure Genesis in Human Hypothalamic Hamartomas
    NIH/NINDS R21NS057786Apr 1, 2008 - Mar 31, 2011
    Role: Principal Investigator
    International Symposium on Dietary Therapies for Epilepsy and Other Neurological
    NIH/NINDS R13NS062642Apr 1, 2008 - Mar 31, 2009
    Role: Principal Investigator
    GABAergic Inhibition and the Ketogenic Diet
    NIH/NINDS K02NS044846Feb 1, 2003 - Jan 31, 2009
    Role: Principal Investigator
    POTASSIUM CHANNELS AND EPILEPTOGENESIS
    NIH/NINDS K08NS001974Jul 23, 1997 - Jun 30, 2004
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Appendino JP, Boelman C, Brna PM, Burneo JG, Claassen CS, Connolly MB, De Guzman M, Federico P, Floyd D, Huntsman R, Javidan M, Jetté N, Jurasek LL, Keezer M, Lau JC, McCoy B, McLachlan R, Ng MC, Nguyen D, Reid A, Rho JM, Snead C, Téllez-Zenteno JF, Wang L, Zak M. POSITION STATEMENT ON THE USE OF MEDICAL CANNABIS FOR THE TREATMENT OF EPILEPSY IN CANADA. Can J Neurol Sci. 2019 Aug 30; 1-39. PMID: 31466531.
      View in: PubMed
    2. Boison D, Rho JM. Epigenetics and epilepsy prevention: The therapeutic potential of adenosine and metabolic therapies. Neuropharmacology. 2019 Aug 13; 107741. PMID: 31419398.
      View in: PubMed
    3. Chard M, Appendino JP, Bello-Espinosa LE, Curtis C, Rho JM, Wei XC, Al-Hertani W. Single-center experience with Beta-propeller protein-associated neurodegeneration (BPAN); expanding the phenotypic spectrum. Mol Genet Metab Rep. 2019 Sep; 20:100483. PMID: 31293896.
      View in: PubMed
    4. Kaushik DK, Bhattacharya A, Mirzaei R, Rawji KS, Ahn Y, Rho JM, Yong VW. Enhanced glycolytic metabolism supports transmigration of brain-infiltrating macrophages in multiple sclerosis. J Clin Invest. 2019 May 21; 130. PMID: 31112527.
      View in: PubMed
    5. Jobst BC, Ben-Menachem E, Chapman KE, Fu A, Goldman A, Hirsch LJ, Jehi LE, Kossoff EH, Plueger M, Rho JM, Schevon CA, Shinnar S, Sperling MR, Simeone TA, Wagner JL, Lado F. Highlights From the Annual Meeting of the American Epilepsy Society 2018. Epilepsy Curr. 2019 May-Jun; 19(3):152-158. PMID: 31050308.
      View in: PubMed
    6. Rho JM, Shao LR, Stafstrom CE. 2-Deoxyglucose and Beta-Hydroxybutyrate: Metabolic Agents for Seizure Control. Front Cell Neurosci. 2019; 13:172. PMID: 31114484.
      View in: PubMed
    7. Rho JM, White HS. Brief history of anti-seizure drug development. Epilepsia Open. 2018 Dec; 3(Suppl Suppl 2):114-119. PMID: 30564769.
      View in: PubMed
    8. Shao LR, Rho JM, Stafstrom CE. Glycolytic inhibition: A novel approach toward controlling neuronal excitability and seizures. Epilepsia Open. 2018 Dec; 3(Suppl Suppl 2):191-197. PMID: 30564778.
      View in: PubMed
    9. Wallace E, Wright S, Schoenike B, Roopra A, Rho JM, Maganti RK. Altered circadian rhythms and oscillation of clock genes and sirtuin 1 in a model of sudden unexpected death in epilepsy. Epilepsia. 2018 08; 59(8):1527-1539. PMID: 30009381.
      View in: PubMed
    10. Almomen M, Rho JM, Scantlebury MH. Infantile Epileptic Encephalopathy With Multiple Genetic Mutations: How Important are Variants of Undetermined Significance? Semin Pediatr Neurol. 2018 07; 26:33-36. PMID: 29961513.
      View in: PubMed
    11. Masino SA, Rho JM. Metabolism and epilepsy: Ketogenic diets as a homeostatic link. Brain Res. 2019 Jan 15; 1703:26-30. PMID: 29883626.
      View in: PubMed
    12. Lewis ML, Kesler M, Candy SA, Rho JM, Pittman QJ. Comorbid epilepsy in autism spectrum disorder: Implications of postnatal inflammation for brain excitability. Epilepsia. 2018 07; 59(7):1316-1326. PMID: 29858515.
      View in: PubMed
    13. Kossoff EH, Zupec-Kania BA, Auvin S, Ballaban-Gil KR, Christina Bergqvist AG, Blackford R, Buchhalter JR, Caraballo RH, Cross JH, Dahlin MG, Donner EJ, Guzel O, Jehle RS, Klepper J, Kang HC, Lambrechts DA, Liu YMC, Nathan JK, Nordli DR, Pfeifer HH, Rho JM, Scheffer IE, Sharma S, Stafstrom CE, Thiele EA, Turner Z, Vaccarezza MM, van der Louw EJTM, Veggiotti P, Wheless JW, Wirrell EC. Optimal clinical management of children receiving dietary therapies for epilepsy: Updated recommendations of the International Ketogenic Diet Study Group. Epilepsia Open. 2018 Jun; 3(2):175-192. PMID: 29881797.
      View in: PubMed
    14. Drummond-Main CD, Rho JM. Electrophysiological characterization of a mitochondrial inner membrane chloride channel in rat brain. FEBS Lett. 2018 05; 592(9):1545-1553. PMID: 29578588.
      View in: PubMed
    15. Ibhazehiebo K, Gavrilovici C, de la Hoz CL, Ma SC, Rehak R, Kaushik G, Meza Santoscoy PL, Scott L, Nath N, Kim DY, Rho JM, Kurrasch DM. A novel metabolism-based phenotypic drug discovery platform in zebrafish uncovers HDACs 1 and 3 as a potential combined anti-seizure drug target. Brain. 2018 03 01; 141(3):744-761. PMID: 29373639.
      View in: PubMed
    16. Lopes F, Keita ÅV, Saxena A, Reyes JL, Mancini NL, Al Rajabi A, Wang A, Baggio CH, Dicay M, van Dalen R, Ahn Y, Carneiro MBH, Peters NC, Rho JM, MacNaughton WK, Girardin SE, Jijon H, Philpott DJ, Söderholm JD, McKay DM. ER-stress mobilization of death-associated protein kinase-1-dependent xenophagy counteracts mitochondria stress-induced epithelial barrier dysfunction. J Biol Chem. 2018 03 02; 293(9):3073-3087. PMID: 29317503.
      View in: PubMed
    17. Simeone TA, Simeone KA, Stafstrom CE, Rho JM. Do ketone bodies mediate the anti-seizure effects of the ketogenic diet? Neuropharmacology. 2018 05 01; 133:233-241. PMID: 29325899.
      View in: PubMed
    18. Chun KC, Ma SC, Oh H, Rho JM, Kim DY. Ketogenic diet-induced extension of longevity in epileptic Kcna1-null mice is influenced by gender and age at treatment onset. Epilepsy Res. 2018 02; 140:53-55. PMID: 29245026.
      View in: PubMed
    19. French JA, Koepp M, Naegelin Y, Vigevano F, Auvin S, Rho JM, Rosenberg E, Devinsky O, Olofsson PS, Dichter MA. Clinical studies and anti-inflammatory mechanisms of treatments. Epilepsia. 2017 07; 58 Suppl 3:69-82. PMID: 28675558.
      View in: PubMed
    20. Cheng N, Alshammari F, Hughes E, Khanbabaei M, Rho JM. Dendritic overgrowth and elevated ERK signaling during neonatal development in a mouse model of autism. PLoS One. 2017; 12(6):e0179409. PMID: 28609458.
      View in: PubMed
    21. Buchhalter JR, D'Alfonso S, Connolly M, Fung E, Michoulas A, Sinasac D, Singer R, Smith J, Singh N, Rho JM. The relationship between d-beta-hydroxybutyrate blood concentrations and seizure control in children treated with the ketogenic diet for medically intractable epilepsy. Epilepsia Open. 2017 09; 2(3):317-321. PMID: 29588960.
      View in: PubMed
    22. Newell C, Johnsen VL, Yee NC, Xu WJ, Klein MS, Khan A, Rho JM, Shearer J. Ketogenic diet leads to O-GlcNAc modification in the BTBRT+tf/j mouse model of autism. Biochim Biophys Acta Mol Basis Dis. 2017 09; 1863(9):2274-2281. PMID: 28502704.
      View in: PubMed
    23. Klement RJ, Feinman RD, Gross EC, Champ CE, D'Agostino DP, Fine EJ, Kämmerer U, Poff A, Rho JM, Seyfried TN, Scheck AC. Need for new review of article on ketogenic dietary regimes for cancer patients. Med Oncol. 2017 06; 34(6):108. PMID: 28452037.
      View in: PubMed
    24. Simeone TA, Simeone KA, Rho JM. Ketone Bodies as Anti-Seizure Agents. Neurochem Res. 2017 Jul; 42(7):2011-2018. PMID: 28397070.
      View in: PubMed
    25. Leal-Campanario R, Alarcon-Martinez L, Rieiro H, Martinez-Conde S, Alarcon-Martinez T, Zhao X, LaMee J, Popp PJ, Calhoun ME, Arribas JI, Schlegel AA, Stasi LL, Rho JM, Inge L, Otero-Millan J, Treiman DM, Macknik SL. Abnormal Capillary Vasodynamics Contribute to Ictal Neurodegeneration in Epilepsy. Sci Rep. 2017 02 27; 7:43276. PMID: 28240297.
      View in: PubMed
    26. Scantlebury MH, Chun KC, Ma SC, Rho JM, Kim DY. Adrenocorticotropic hormone protects learning and memory function in epileptic Kcna1-null mice. Neurosci Lett. 2017 04 03; 645:14-18. PMID: 28249786.
      View in: PubMed
    27. Kim DY, Zhang FX, Nakanishi ST, Mettler T, Cho IH, Ahn Y, Hiess F, Chen L, Sullivan PG, Chen SR, Zamponi GW, Rho JM. Carisbamate blockade of T-type voltage-gated calcium channels. Epilepsia. 2017 04; 58(4):617-626. PMID: 28230232.
      View in: PubMed
    28. Cheng N, Rho JM, Masino SA. Metabolic Dysfunction Underlying Autism Spectrum Disorder and Potential Treatment Approaches. Front Mol Neurosci. 2017; 10:34. PMID: 28270747.
      View in: PubMed
    29. Newell C, Shutt TE, Ahn Y, Hittel DS, Khan A, Rho JM, Shearer J. Tissue Specific Impacts of a Ketogenic Diet on Mitochondrial Dynamics in the BTBRT+tf/j Mouse. Front Physiol. 2016; 7:654. PMID: 28082920.
      View in: PubMed
    30. Newell C, Bomhof MR, Reimer RA, Hittel DS, Rho JM, Shearer J. Ketogenic diet modifies the gut microbiota in a murine model of autism spectrum disorder. Mol Autism. 2016; 7(1):37. PMID: 27594980.
      View in: PubMed
    31. Cheng N, Khanbabaei M, Murari K, Rho JM. Disruption of visual circuit formation and refinement in a mouse model of autism. Autism Res. 2017 Feb; 10(2):212-223. PMID: 27529416.
      View in: PubMed
    32. Mychasiuk R, Rho JM. Genetic modifications associated with ketogenic diet treatment in the BTBRT+Tf/J mouse model of autism spectrum disorder. Autism Res. 2017 Mar; 10(3):456-471. PMID: 27529337.
      View in: PubMed
    33. Simeone KA, Matthews SA, Rho JM, Simeone TA. Ketogenic diet treatment increases longevity in Kcna1-null mice, a model of sudden unexpected death in epilepsy. Epilepsia. 2016 08; 57(8):e178-82. PMID: 27346881.
      View in: PubMed
    34. Jiang Y, Gavrilovici C, Chansard M, Liu RH, Kiroski I, Parsons K, Park SK, Teskey GC, Rho JM, Nguyen MD. Ndel1 and Reelin Maintain Postnatal CA1 Hippocampus Integrity. J Neurosci. 2016 06 15; 36(24):6538-52. PMID: 27307241.
      View in: PubMed
    35. Rogawski MA, Löscher W, Rho JM. Mechanisms of Action of Antiseizure Drugs and the Ketogenic Diet. Cold Spring Harb Perspect Med. 2016 05 02; 6(5). PMID: 26801895.
      View in: PubMed
    36. Klein MS, Newell C, Bomhof MR, Reimer RA, Hittel DS, Rho JM, Vogel HJ, Shearer J. Metabolomic Modeling To Monitor Host Responsiveness to Gut Microbiota Manipulation in the BTBR(T+tf/j) Mouse. J Proteome Res. 2016 Apr 01; 15(4):1143-50. PMID: 26928523.
      View in: PubMed
    37. Smith J, Rho JM, Teskey GC. Ketogenic diet restores aberrant cortical motor maps and excitation-to-inhibition imbalance in the BTBR mouse model of autism spectrum disorder. Behav Brain Res. 2016 May 01; 304:67-70. PMID: 26876011.
      View in: PubMed
    38. Myers KA, Rho JM, Wei XC. Teaching NeuroImages: MRI findings in X-linked adrenoleukodystrophy. Neurology. 2015 Oct 27; 85(17):e132-3. PMID: 26503591.
      View in: PubMed
    39. Rho JM. How does the ketogenic diet induce anti-seizure effects? Neurosci Lett. 2017 01 10; 637:4-10. PMID: 26222258.
      View in: PubMed
    40. Rho JM. Inhibition of Lactate Dehydrogenase to Treat Epilepsy. N Engl J Med. 2015 Jul 09; 373(2):187-9. PMID: 26154793.
      View in: PubMed
    41. Rajapakse T, Hinnell CJ, Wei XC, Mah JK, Rho JM. "Tinkle Tinkle Little Girl, How We Wonder Why You Can't": An Unusual AIDP-like Syndrome in a Toddler. Can J Neurol Sci. 2015 Jul; 42(4):274-7. PMID: 25990009.
      View in: PubMed
    42. Wallace E, Kim DY, Kim KM, Chen S, Blair Braden B, Williams J, Jasso K, Garcia A, Rho JM, Bimonte-Nelson H, Maganti R. Differential effects of duration of sleep fragmentation on spatial learning and synaptic plasticity in pubertal mice. Brain Res. 2015 Jul 30; 1615:116-128. PMID: 25957790.
      View in: PubMed
    43. Kim DY, Simeone KA, Simeone TA, Pandya JD, Wilke JC, Ahn Y, Geddes JW, Sullivan PG, Rho JM. Ketone bodies mediate antiseizure effects through mitochondrial permeability transition. Ann Neurol. 2015 Jul; 78(1):77-87. PMID: 25899847.
      View in: PubMed
    44. Lee B, Ahn Y, Kang SM, Park Y, Jeon YJ, Rho JM, Kim SW. Stoichiometric expression of mtHsp40 and mtHsp70 modulates mitochondrial morphology and cristae structure via Opa1L cleavage. Mol Biol Cell. 2015 Jun 15; 26(12):2156-67. PMID: 25904328.
      View in: PubMed
    45. Kim DY, Abdelwahab MG, Lee SH, O'Neill D, Thompson RJ, Duff HJ, Sullivan PG, Rho JM. Ketones prevent oxidative impairment of hippocampal synaptic integrity through KATP channels. PLoS One. 2015; 10(4):e0119316. PMID: 25848768.
      View in: PubMed
    46. Bello-Espinosa LE, Rajapakse T, Rho JM, Buchhalter J. Efficacy of intravenous immunoglobulin in a cohort of children with drug-resistant epilepsy. Pediatr Neurol. 2015 May; 52(5):509-16. PMID: 25882078.
      View in: PubMed
    47. Nicolini C, Ahn Y, Michalski B, Rho JM, Fahnestock M. Decreased mTOR signaling pathway in human idiopathic autism and in rats exposed to valproic acid. Acta Neuropathol Commun. 2015 Jan 20; 3:3. PMID: 25627160.
      View in: PubMed
    48. Hartman AL, Rho JM. The New Ketone Alphabet Soup: BHB, HCA, and HDAC. Epilepsy Curr. 2014 Nov-Dec; 14(6):355-7. PMID: 25678874.
      View in: PubMed
    49. Ahn Y, Narous M, Tobias R, Rho JM, Mychasiuk R. The ketogenic diet modifies social and metabolic alterations identified in the prenatal valproic acid model of autism spectrum disorder. Dev Neurosci. 2014; 36(5):371-80. PMID: 25011527.
      View in: PubMed
    50. Smith JD, Rho JM, Masino SA, Mychasiuk R. Inchworming: a novel motor stereotypy in the BTBR T+ Itpr3tf/J mouse model of autism. J Vis Exp. 2014 Jul 05; (89). PMID: 25046063.
      View in: PubMed
    51. Stotz SC, Scott LO, Drummond-Main C, Avchalumov Y, Girotto F, Davidsen J, Gómez-Gárcia MR, Rho JM, Pavlov EV, Colicos MA. Inorganic polyphosphate regulates neuronal excitability through modulation of voltage-gated channels. Mol Brain. 2014 May 31; 7:42. PMID: 24886461.
      View in: PubMed
    52. Gano LB, Patel M, Rho JM. Ketogenic diets, mitochondria, and neurological diseases. J Lipid Res. 2014 Nov; 55(11):2211-28. PMID: 24847102.
      View in: PubMed
    53. Swann JW, Rho JM. How is homeostatic plasticity important in epilepsy? Adv Exp Med Biol. 2014; 813:123-31. PMID: 25012372.
      View in: PubMed
    54. Ruskin DN, Svedova J, Cote JL, Sandau U, Rho JM, Kawamura M, Boison D, Masino SA. Ketogenic diet improves core symptoms of autism in BTBR mice. PLoS One. 2013; 8(6):e65021. PMID: 23755170.
      View in: PubMed
    55. Simeone TA, Simeone KA, Samson KK, Kim DY, Rho JM. Loss of the Kv1.1 potassium channel promotes pathologic sharp waves and high frequency oscillations in in vitro hippocampal slices. Neurobiol Dis. 2013 Jun; 54:68-81. PMID: 23466697.
      View in: PubMed
    56. Goia E, Hamilton L, Chan J, Wei XC, Mah JK, Rho JM. Unilateral foot drop as an initial presentation of a brain tumor in a child. J Child Neurol. 2014 Jul; 29(7):955-8. PMID: 23456535.
      View in: PubMed
    57. Girotto F, Scott L, Avchalumov Y, Harris J, Iannattone S, Drummond-Main C, Tobias R, Bello-Espinosa L, Rho JM, Davidsen J, Teskey GC, Colicos MA. High dose folic acid supplementation of rats alters synaptic transmission and seizure susceptibility in offspring. Sci Rep. 2013; 3:1465. PMID: 23492951.
      View in: PubMed
    58. Patel M, Rho JM. Sweets Are BAD for Seizures. Epilepsy Curr. 2012 Nov; 12(6):218-9. PMID: 23447715.
      View in: PubMed
    59. Kobow K, Auvin S, Jensen F, Löscher W, Mody I, Potschka H, Prince D, Sierra A, Simonato M, Pitkänen A, Nehlig A, Rho JM. Finding a better drug for epilepsy: antiepileptogenesis targets. Epilepsia. 2012 Nov; 53(11):1868-76. PMID: 23061663.
      View in: PubMed
    60. Kim DY, Hao J, Liu R, Turner G, Shi FD, Rho JM. Inflammation-mediated memory dysfunction and effects of a ketogenic diet in a murine model of multiple sclerosis. PLoS One. 2012; 7(5):e35476. PMID: 22567104.
      View in: PubMed
    61. Abdelwahab MG, Fenton KE, Preul MC, Rho JM, Lynch A, Stafford P, Scheck AC. The ketogenic diet is an effective adjuvant to radiation therapy for the treatment of malignant glioma. PLoS One. 2012; 7(5):e36197. PMID: 22563484.
      View in: PubMed
    62. Stafstrom CE, Rho JM. The ketogenic diet as a treatment paradigm for diverse neurological disorders. Front Pharmacol. 2012; 3:59. PMID: 22509165.
      View in: PubMed
    63. Rho JM. Adenosine: a fundamental factor formed from Fatty feasts for fighting fits? Epilepsy Curr. 2012 Jan; 12(1):19-21. PMID: 22368522.
      View in: PubMed
    64. Rho JM, Stafstrom CE. The ketogenic diet: what has science taught us? Epilepsy Res. 2012 Jul; 100(3):210-7. PMID: 21856126.
      View in: PubMed
    65. Chapman KE, Kim DY, Rho JM, Ng YT, Kerrigan JF. Ketogenic diet in the treatment of seizures associated with hypothalamic hamartomas. Epilepsy Res. 2011 May; 94(3):218-21. PMID: 21377333.
      View in: PubMed
    66. Cárdenas JF, Rho JM, Kirton A. Pediatric stroke. Childs Nerv Syst. 2011 Sep; 27(9):1375-90. PMID: 21336993.
      View in: PubMed
    67. Simeone KA, Sabesan S, Kim DY, Kerrigan JF, Rho JM, Simeone TA. L-Type calcium channel blockade reduces network activity in human epileptic hypothalamic hamartoma tissue. Epilepsia. 2011 Mar; 52(3):531-40. PMID: 21269296.
      View in: PubMed
    68. Pinter JD, Rho JM. Pediatric neuropharmacotherapeutics. Introduction. Semin Pediatr Neurol. 2010 Dec; 17(4):207. PMID: 21183125.
      View in: PubMed
    69. Rho JM. How does altered metabolism lead to seizure control? Partially filling the knowledge gap. Epilepsy Curr. 2010 Nov; 10(6):159-61. PMID: 21157545.
      View in: PubMed
    70. Stafford P, Abdelwahab MG, Kim DY, Preul MC, Rho JM, Scheck AC. The ketogenic diet reverses gene expression patterns and reduces reactive oxygen species levels when used as an adjuvant therapy for glioma. Nutr Metab (Lond). 2010 Sep 10; 7:74. PMID: 20831808.
      View in: PubMed
    71. Rho JM. Another Look at Early GABAergic Neurotransmission: Maybe It's Not So Exciting After All! Epilepsy Curr. 2010 Sep; 10(5):128-30. PMID: 20944825.
      View in: PubMed
    72. Kim DY, Vallejo J, Rho JM. Ketones prevent synaptic dysfunction induced by mitochondrial respiratory complex inhibitors. J Neurochem. 2010 Jul; 114(1):130-41. PMID: 20374433.
      View in: PubMed
    73. Stein D, Chetty M, Rho JM. A "happy" toddler presenting with sudden, life-threatening seizures. Semin Pediatr Neurol. 2010 Mar; 17(1):35-8. PMID: 20434691.
      View in: PubMed
    74. Fenoglio-Simeone K, Mazarati A, Sefidvash-Hockley S, Shin D, Wilke J, Milligan H, Sankar R, Rho JM, Maganti R. Anticonvulsant effects of the selective melatonin receptor agonist ramelteon. Epilepsy Behav. 2009 Sep; 16(1):52-7. PMID: 19682955.
      View in: PubMed
    75. Kossoff EH, Zupec-Kania BA, Rho JM. Ketogenic diets: an update for child neurologists. J Child Neurol. 2009 Aug; 24(8):979-88. PMID: 19535814.
      View in: PubMed
    76. Cardenas JF, Rho JM, Ng YT. Reversible lamotrigine-induced neurobehavioral disturbances in children with epilepsy. J Child Neurol. 2010 Feb; 25(2):182-7. PMID: 19494356.
      View in: PubMed
    77. Fenoglio-Simeone KA, Wilke JC, Milligan HL, Allen CN, Rho JM, Maganti RK. Ketogenic diet treatment abolishes seizure periodicity and improves diurnal rhythmicity in epileptic Kcna1-null mice. Epilepsia. 2009 Sep; 50(9):2027-34. PMID: 19490051.
      View in: PubMed
    78. Kossoff EH, Rho JM. Ketogenic diets: evidence for short- and long-term efficacy. Neurotherapeutics. 2009 Apr; 6(2):406-14. PMID: 19332337.
      View in: PubMed
    79. Rho JM. Arresting a seizure by dropping a little Acid. Epilepsy Curr. 2009 Mar-Apr; 9(2):55-6. PMID: 19421382.
      View in: PubMed
    80. Kim DY, Fenoglio KA, Kerrigan JF, Rho JM. Bicarbonate contributes to GABAA receptor-mediated neuronal excitation in surgically resected human hypothalamic hamartomas. Epilepsy Res. 2009 Jan; 83(1):89-93. PMID: 19022626.
      View in: PubMed
    81. Maalouf M, Rho JM. Oxidative impairment of hippocampal long-term potentiation involves activation of protein phosphatase 2A and is prevented by ketone bodies. J Neurosci Res. 2008 Nov 15; 86(15):3322-30. PMID: 18646208.
      View in: PubMed
    82. Rho JM, Sankar R. The ketogenic diet in a pill: is this possible? Epilepsia. 2008 Nov; 49 Suppl 8:127-33. PMID: 19049610.
      View in: PubMed
    83. Davis LM, Rho JM, Sullivan PG. UCP-mediated free fatty acid uncoupling of isolated cortical mitochondria from fasted animals: correlations to dietary modulations. Epilepsia. 2008 Nov; 49 Suppl 8:117-9. PMID: 19049607.
      View in: PubMed
    84. Stafstrom CE, Zupec-Kania B, Rho JM. Epilepsia. Ketogenic diet and treatments. Introduction/perspectives. Epilepsia. 2008 Nov; 49 Suppl 8:1-2. PMID: 19049573.
      View in: PubMed
    85. Maalouf M, Rho JM, Mattson MP. The neuroprotective properties of calorie restriction, the ketogenic diet, and ketone bodies. Brain Res Rev. 2009 Mar; 59(2):293-315. PMID: 18845187.
      View in: PubMed
    86. Kossoff EH, Zupec-Kania BA, Amark PE, Ballaban-Gil KR, Christina Bergqvist AG, Blackford R, Buchhalter JR, Caraballo RH, Helen Cross J, Dahlin MG, Donner EJ, Klepper J, Jehle RS, Kim HD, Christiana Liu YM, Nation J, Nordli DR, Pfeifer HH, Rho JM, Stafstrom CE, Thiele EA, Turner Z, Wirrell EC, Wheless JW, Veggiotti P, Vining EP. Optimal clinical management of children receiving the ketogenic diet: recommendations of the International Ketogenic Diet Study Group. Epilepsia. 2009 Feb; 50(2):304-17. PMID: 18823325.
      View in: PubMed
    87. Wu J, DeChon J, Xue F, Li G, Ellsworth K, Gao M, Liu Q, Yang K, Zheng C, He P, Tu J, Kim DY, Rho JM, Rekate H, Kerrigan JF, Chang Y. GABA(A) receptor-mediated excitation in dissociated neurons from human hypothalamic hamartomas. Exp Neurol. 2008 Oct; 213(2):397-404. PMID: 18675803.
      View in: PubMed
    88. Davis LM, Pauly JR, Readnower RD, Rho JM, Sullivan PG. Fasting is neuroprotective following traumatic brain injury. J Neurosci Res. 2008 Jun; 86(8):1812-22. PMID: 18241053.
      View in: PubMed
    89. Rho JM. Can reducing sugar retard kindling? Epilepsy Curr. 2008 May-Jun; 8(3):83-4. PMID: 18488064.
      View in: PubMed
    90. Kim DY, Rho JM. The ketogenic diet and epilepsy. Curr Opin Clin Nutr Metab Care. 2008 Mar; 11(2):113-20. PMID: 18301085.
      View in: PubMed
    91. Kim DY, Fenoglio KA, Simeone TA, Coons SW, Wu J, Chang Y, Kerrigan JF, Rho JM. GABAA receptor-mediated activation of L-type calcium channels induces neuronal excitation in surgically resected human hypothalamic hamartomas. Epilepsia. 2008 May; 49(5):861-71. PMID: 18076645.
      View in: PubMed
    92. Rho JM. Substantia(ting) ketone body effects on neuronal excitability. Epilepsy Curr. 2007 Sep-Oct; 7(5):142-4. PMID: 17998978.
      View in: PubMed
    93. Fenoglio KA, Wu J, Kim DY, Simeone TA, Coons SW, Rekate H, Rho JM, Kerrigan JF. Hypothalamic hamartoma: basic mechanisms of intrinsic epileptogenesis. Semin Pediatr Neurol. 2007 Jun; 14(2):51-9. PMID: 17544947.
      View in: PubMed
    94. Sankar R, Rho JM. Do seizures affect the developing brain? Lessons from the laboratory. J Child Neurol. 2007 May; 22(5 Suppl):21S-9S. PMID: 17690084.
      View in: PubMed
    95. Wu J, Chang Y, Li G, Xue F, DeChon J, Ellsworth K, Liu Q, Yang K, Bahadroani N, Zheng C, Zhang J, Rekate H, Rho JM, Kerrigan JF. Electrophysiological properties and subunit composition of GABAA receptors in patients with gelastic seizures and hypothalamic hamartoma. J Neurophysiol. 2007 Jul; 98(1):5-15. PMID: 17428906.
      View in: PubMed
    96. Kim DY, Davis LM, Sullivan PG, Maalouf M, Simeone TA, van Brederode J, Rho JM. Ketone bodies are protective against oxidative stress in neocortical neurons. J Neurochem. 2007 Jun; 101(5):1316-26. PMID: 17403035.
      View in: PubMed
    97. Rho JM, Rogawski MA. The ketogenic diet: stoking the powerhouse of the cell. Epilepsy Curr. 2007 Mar-Apr; 7(2):58-60. PMID: 17505556.
      View in: PubMed
    98. Bough KJ, Rho JM. Anticonvulsant mechanisms of the ketogenic diet. Epilepsia. 2007 Jan; 48(1):43-58. PMID: 17241207.
      View in: PubMed
    99. Maalouf M, Takahashi CD, Reinkensmeyer DJ, Cooper DM, Rho JM. Impaired motor control in patients with benign focal epilepsy of childhood. J Child Neurol. 2006 Feb; 21(2):157-60. PMID: 16566883.
      View in: PubMed
    100. Wu J, Xu L, Kim DY, Rho JM, St John PA, Lue LF, Coons S, Ellsworth K, Nowak L, Johnson E, Rekate H, Kerrigan JF. Electrophysiological properties of human hypothalamic hamartomas. Ann Neurol. 2005 Sep; 58(3):371-82. PMID: 16130091.
      View in: PubMed
    101. Kim HL, Aldridge J, Rho JM. Clinical experience with zonisamide monotherapy and adjunctive therapy in children with epilepsy at a tertiary care referral center. J Child Neurol. 2005 Mar; 20(3):212-9. PMID: 15832611.
      View in: PubMed
    102. Noh HS, Lee HP, Kim DW, Kang SS, Cho GJ, Rho JM, Choi WS. A cDNA microarray analysis of gene expression profiles in rat hippocampus following a ketogenic diet. Brain Res Mol Brain Res. 2004 Oct 22; 129(1-2):80-7. PMID: 15469884.
      View in: PubMed
    103. Rho JM, Sarnat HB, Sullivan PG, Robbins CA, Kim DW. Lack of long-term histopathologic changes in brain and skeletal muscle of mice treated with a ketogenic diet. J Child Neurol. 2004 Jul; 19(7):555-7. PMID: 15526964.
      View in: PubMed
    104. Simeone TA, Sanchez RM, Rho JM. Molecular biology and ontogeny of glutamate receptors in the mammalian central nervous system. J Child Neurol. 2004 May; 19(5):343-60; discussion 361. PMID: 15224708.
      View in: PubMed
    105. Sullivan PG, Rippy NA, Dorenbos K, Concepcion RC, Agarwal AK, Rho JM. The ketogenic diet increases mitochondrial uncoupling protein levels and activity. Ann Neurol. 2004 Apr; 55(4):576-80. PMID: 15048898.
      View in: PubMed
    106. Rho JM. Basic science behind the catastrophic epilepsies. Epilepsia. 2004; 45 Suppl 5:5-11. PMID: 15283705.
      View in: PubMed
    107. Donevan SD, White HS, Anderson GD, Rho JM. Voltage-dependent block of N-methyl-D-aspartate receptors by the novel anticonvulsant dibenzylamine, a bioactive constituent of L-(+)-beta-hydroxybutyrate. Epilepsia. 2003 Oct; 44(10):1274-9. PMID: 14510820.
      View in: PubMed
    108. Bough KJ, Schwartzkroin PA, Rho JM. Calorie restriction and ketogenic diet diminish neuronal excitability in rat dentate gyrus in vivo. Epilepsia. 2003 Jun; 44(6):752-60. PMID: 12790887.
      View in: PubMed
    109. Bingel U, Pinter JD, Sotero de Menezes M, Rho JM. Intravenous immunoglobulin as adjunctive therapy for juvenile spasms. J Child Neurol. 2003 Jun; 18(6):379-82. PMID: 12886970.
      View in: PubMed
    110. Simeone TA, Donevan SD, Rho JM. Molecular biology and ontogeny of gamma-aminobutyric acid (GABA) receptors in the mammalian central nervous system. J Child Neurol. 2003 Jan; 18(1):39-48; discussion 49. PMID: 12661937.
      View in: PubMed
    111. de Menezes MA, Rho JM. Clinical and electrographic features of epileptic spasms persisting beyond the second year of life. Epilepsia. 2002 Jun; 43(6):623-30. PMID: 12060022.
      View in: PubMed
    112. Rho JM, Anderson GD, Donevan SD, White HS. Acetoacetate, acetone, and dibenzylamine (a contaminant in l-(+)-beta-hydroxybutyrate) exhibit direct anticonvulsant actions in vivo. Epilepsia. 2002 Apr; 43(4):358-61. PMID: 11952765.
      View in: PubMed
    113. Grant AC, Rho JM. Ictal EEG patterns in band heterotopia. Epilepsia. 2002 Apr; 43(4):403-7. PMID: 11952771.
      View in: PubMed
    114. Storey TW, Rho JM, White SS, Sankar R, Szot P. Age-dependent differences in flurothyl-induced c-fos and c-jun mRNA expression in the mouse brain. Dev Neurosci. 2002; 24(4):294-9. PMID: 12457067.
      View in: PubMed